v3.26.1
Collaborative Arrangements - Bayer AG (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales $ 16,607 $ 15,806 $ 32,893 $ 31,335  
Cost of sales 4,395 3,557 8,590 6,976  
Selling, general and administrative 2,904 2,649 5,604 5,202  
Research and development 9,741 4,048 22,333 7,669  
Other current assets 36,679   36,679   $ 43,516
Accrued and other current liabilities 14,725   14,725   14,468
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue from collaborative arrangement 126 123 235 229  
Sales 213 214 409 397  
Cost of sales 67 61 134 120  
Selling, general and administrative 11 29 23 58  
Research and development 10 20 27 43  
Other current assets 166   166   167
Accrued and other current liabilities 86   86   $ 81
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Adempas          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales 78 80 156 147  
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Verquvo          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales $ 9 $ 11 $ 18 $ 21